Skip to content

Galena biopharma reverse stock split

Galena biopharma reverse stock split

Galena intends to effect a reverse stock split of the outstanding shares of Galena common stock, at a ratio of not less than 1-for-10 and not greater than 1-for-30, with the exact ratio and effective time of the reverse stock split to be determined by the Galena board of directors and agreed upon by SELLAS and publicly announced by press release. Galena Biopharma (Nasdaq: GALE) Shares Reflect the Drama Feb 07, 2017 · Galena Biopharma, Inc. – Nasdaq: GALE. Shares of biotech company Galena Biopharma have averaged less than 2 million shares traded daily. Yesterday over 32 million shares traded hands and GALE, traded on the Nasdaq, gained 17.5% as they settled at $1.41.However, it should be noted that GALE reached a high of $2.41 earlier in the day before … GALENA BIOPHARMA, INC. stock split to be determined by the Galena board of directors and agreed upon by SELLAS and publicly announced by press release. Accordingly, on a post-reverse split basis, the Exchange Ratio would be within a range of approximately 159.0746 to 53.0249 post-split shares of Galena common stock for each SELLAS Share. Company Update (NASDAQ:GALE): Galena Biopharma Inc Shares ... Dec 29, 2017 · Therefore, every 30 shares of Galena common stock issued and outstanding or held by Galena in treasury immediately prior to the effective time of the reverse stock split will automatically be

View Galena Biopharma , Inc. (www.galenabiopharma.com) location in New with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio.

About GALE - Split History GALE (GALE) has 1 split in our GALE split history database. The split for GALE took place on November 14, 2016. This was a 1 for 20 reverse split, meaning for each 20 shares of GALE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split. Galena Biopharma Announces Reverse Stock Split – StockGuru ...

Galena Biopharma (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company was acquired by SELLAS Life Sciences Group Ltd. through a reverse merger transaction. In November 2012, an anonymous internet report caused Galena stock to decline. "RXi to split into two public companies".

Galena intends to effect a reverse stock split of the outstanding shares of Galena common stock, at a ratio of not less than 1-for-10 and not greater than 1-for-30, with the exact ratio and effective time of the reverse stock split to be determined by the Galena board of directors and agreed upon by SELLAS and publicly announced by press release. Galena Biopharma (Nasdaq: GALE) Shares Reflect the Drama Feb 07, 2017 · Galena Biopharma, Inc. – Nasdaq: GALE. Shares of biotech company Galena Biopharma have averaged less than 2 million shares traded daily. Yesterday over 32 million shares traded hands and GALE, traded on the Nasdaq, gained 17.5% as they settled at $1.41.However, it should be noted that GALE reached a high of $2.41 earlier in the day before …

GALE (GALE) has 1 split in our GALE split history database. The split for GALE took place on November 14, 2016. This was a 1 for 20 reverse split, meaning for each 20 shares of GALE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

SELLAS Life Sciences Group, Inc. (SLS) FORM 8-K (the Reverse Stock Split Additional Information about the Merger involving Galena Biopharma, Inc. … Here's What's Moving Galena Biopharma, Inc. (NASDAQ:GALE ... Jan 02, 2018 · The two companies in focus are Galena Biopharma, Inc. (NASDAQ:GALE) and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). 29 that it was set to effect a reverse stock split of the issued shares Galena Biopharma's (GALE) CEO Mark Schwartz on Q3 2016 ... Galena Biopharma, Inc. (GALE) Q3 2016 Earnings Conference Call November 09, 2016, 17:00 ET Executives Mark Schwartz - President & CEO John Burns - VP … Galena Biopharma, Inc. Stockholders Approve ... - EconoTimes

Galena Biopharma, Inc. (GALE) Q3 2016 Earnings Conference Call November 09, 2016, 17:00 ET Executives Mark Schwartz - President & CEO John Burns - VP …

Galena Biopharma (Nasdaq: GALE) Shares Reflect the Drama Feb 07, 2017 · Galena Biopharma, Inc. – Nasdaq: GALE. Shares of biotech company Galena Biopharma have averaged less than 2 million shares traded daily. Yesterday over 32 million shares traded hands and GALE, traded on the Nasdaq, gained 17.5% as they settled at $1.41.However, it should be noted that GALE reached a high of $2.41 earlier in the day before … GALENA BIOPHARMA, INC. stock split to be determined by the Galena board of directors and agreed upon by SELLAS and publicly announced by press release. Accordingly, on a post-reverse split basis, the Exchange Ratio would be within a range of approximately 159.0746 to 53.0249 post-split shares of Galena common stock for each SELLAS Share.

Apex Business WordPress Theme | Designed by Crafthemes